Intelligent Suicide Risk Assessment in Clinical Research
AVERT™ is ERT’s electronic suicide risk assessment system that provides simple audio (phone) or visual (web or tablet) solutions that are efficiently and effectively implemented in any clinical study. When utilizing AVERT, patients or clinicians complete the suicide risk assessment directly in an electronic format. By doing so, investigative sites can count on systematic, comprehensive, and consistent assessments that reduce both patient and site staff burden when compared to traditional paper methods. AVERT electronically deploys scientifically proven suicide risk assessments, which includes the application the Columbia-Suicide Severity Rating Scale (C-SSRS) and the patient self-reported version of the Columbia (eC-SSRS), which are cited in the draft FDA SIB guidance as acceptable methods for assessing suicide risk.
The Patient-Reported eC-SSRS
By working closely with Dr. Kelly Posner, the lead author of the C-SSRS, ERT developed an electronic fully-structured, patient-reported version of the C-SSRS called the eC-SSRS. The eC-SSRS is available in tablet, IVR and web versions and provides considerable benefits over the traditional C-SSRS. Although very simple and low burden to the patient, the eC-SSRS implements a complex systematic structure of questions that logically branch to appropriate follow-up questions based on patient responses. This self-reported approach increases patient candor and ensures consist deployment across all patients, at all sites, in all languages.